Cellyan Biotechnology Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. The company employs 27 full-time employees The company went IPO on 2025-01-15. The firm mainly provides two services. The supply chain services mainly provide OTC pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services mainly provide OTC pharmaceutical cross-border procurement and distribution services.
HKPD stock price ended at $0.42 on 星期五, after rising 2.44%
On the latest trading day Aug 07, 2026, the stock price of HKPD rose by 2.44%, climbing from $0.40 to $0.42. Throughout the session, the stock experienced a volatility of 7.69%, with prices fluctuating between a daily low of $0.39 and a high of $0.42. Alongside this price increase, trading volume also rose by 1.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 17.8K shares were traded, amounting to a market value of approximately $9.8M.